The Department of Justice has announced that the Subcutaneous Drug Development & Delivery Consortium, Inc. has updated its membership with the addition of Sanofi, a company from Paris, France. This notification was filed under the National Cooperative Research and Production Act, which allows for certain antitrust protections. The consortium's project membership remains open, and it plans to disclose further changes in the future. Previously, an initial notice was published by the Department of Justice in the Federal Register in December 2020.
Simple Explanation
In the Federal Register, the Justice Department said a group that works on medicines you can take under your skin added a new member, Sanofi, from France, to help with its projects. This notice means they're making sure everything is fair with rules that keep big companies from getting too powerful.